-
Mashup Score: 4
expert roundtables by David Scott Miller, MD, FACOG, FACS; Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; Pamela T. Soliman, MD, MPH Long-term survival in patients with endometrial cancer has increased with our understanding of the disease and its subtypes. Understanding predictive factors for survival in patients with endometrial cancer can help clinicians match each patient with the best treatment option. What are the best predictors of survival in patients with endometrial cancer? “As a result of The
Source: expertperspectives.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9State-of-the-Art Management of Advanced or Recurrent Endometrial Cancer - Expert Perspectives - 1 year(s) ago
Standard options to treat primary advanced or recurrent endometrial cancer after failure of platinum-based chemotherapy have been limited. The emergence of immunotherapy and targeted therapies in this space has been encouraging, and researchers are aiming to build on these initial successes.
Source: expertperspectives.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7
Some patients with endometrial cancer are deemed medically inoperable due to factors such as advanced age and comorbidities that increase perioperative risk. For such patients, definitive radiation therapy is an option that can result in favorable local control and improved survival outcomes.
Source: expertperspectives.comCategories: General Medicine News, Hem/OncsTweet
Predictors of Long-term #Survival in #EndometrialCancer. From Expert Perspectives in Oncology (@eponcology) with Drs. Alexander Olawaiye and Pamela T. Soliman (@PamSolimanMD). #tcga https://t.co/TgWXIIu8RO